Immune checkpoint expression score is an independent prognostic biomarker in resectable non-small cell lung cancer

被引：0
|
作者：
Uso, Marta [1 ,2 ]
Jantus-Lewintre, Eloisa [2 ,3 ]
Sirera, Rafael [3 ]
Calabuig, Silvia [1 ,2 ]
Pastor, Enrique [4 ]
Forteza, Jeronimo [5 ]
Camps, Carlos [1 ,4 ]
机构：
[1] Univ Valencia, Valencia, Spain
[2] Fdn Invest Hosp Gen Univ Valencia, Valencia, Spain
[3] Univ Politecn Valencia, E-46022 Valencia, Spain
[4] Hosp Gen Univ Valencia, Valencia, Spain
[5] Inst Valenciano Patol, Valencia, Spain
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-4330
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4330
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Molecular prognostic factors in resectable non-small cell lung cancer
    Vielh, P
    Spano, JP
    Grenier, J
    Le Chevalier, I
    Soria, JC
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 53 (03) : 193 - 197
  • [22] Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Biomarkers of Immune-Checkpoint Inhibitor for Non-Small Cell Lung Cancer
    Minami, Seigo
    Ihara, Shouichi
    Ikuta, Shouko
    Komuta, Kiyoshi
    WORLD JOURNAL OF ONCOLOGY, 2019, 10 (02) : 90 - 100
  • [23] The role of an immune checkpoint score in resected non-small cell lung cancer patients' prognosis
    Berardi, Rossana
    Rinaldi, Silvia
    JOURNAL OF THORACIC DISEASE, 2017, 9 (10) : 3480 - 3482
  • [24] Osteopontin is a prognostic biomarker in non-small cell lung cancer
    Rud, Ane Kongsgaard
    Boye, Kjetil
    Oijordsbakken, Miriam
    Lund-Iversen, Marius
    Halvorsen, Ann Rita
    Solberg, Steinar K.
    Berge, Gisle
    Helland, Aslaug
    Brustugun, Odd Terje
    Maelandsmo, Gunhild M.
    BMC CANCER, 2013, 13
  • [25] Effect of Chemotherapeutics on In Vitro Immune Checkpoint Expression in Non-Small Cell Lung Cancer
    Zhao, Yu
    Wang, Zhe
    Shi, Xiuhuan
    Liu, Ting
    Yu, Wenwen
    Ren, Xiubao
    Zhao, Hua
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [26] Effect of Chemotherapeutics on In Vitro Immune Checkpoint Expression in Non-Small Cell Lung Cancer
    Zhao, Yu
    Wang, Zhe
    Shi, Xiuhuan
    Liu, Ting
    Yu, Wenwen
    Ren, Xiubao
    Zhao, Hua
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [27] Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Shoji, Fumihiro
    Takeoka, Hiroaki
    Kozuma, Yuka
    Toyokawa, Gouji
    Yamazaki, Koji
    Ichiki, Masao
    Takeo, Sadanori
    LUNG CANCER, 2019, 136 : 45 - 51
  • [28] Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)
    Topchu, Iuliia
    Karnaukhov, Nikolai
    Mazitova, Alexandra
    Yugai, Veronika
    Voloshin, Mark
    Tikhomirova, Mariya
    Kit, Oleg
    Frantsiyants, Elena
    Kharin, Leonid
    Airapetova, Tamara
    Ratner, Ekaterina
    Sabirov, Alexey
    Abramova, Zinaida
    Serebriiskii, Iliya
    Boumber, Yanis
    Deneka, Alexander
    JOURNAL OF THORACIC DISEASE, 2021, 13 (03) : 1370 - 1379
  • [29] Neoadjuvant Immune Checkpoint Inhibitor plus Chemotherapy for Resectable Non-small Cell Lung Cancer in Real World
    Chen, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S579 - S580
  • [30] Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC).
    Deneka, Alexander
    Kharin, Leonid
    Karnaukhov, Nikolay S.
    Voloshin, Mark
    Ayrapetova, Tamara G.
    Ratner, Elena
    Sabirov, Alexey
    Topchu, Yulia
    Mazitova, Alexandra
    Abramova, Zinaida
    Yugai, Veronika
    Frantsiyants, Elena M.
    Kit, Oleg Ivanovich
    Boumber, Yanis
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345